Eagle’s Eye View: Sunday, November 12 — Daily Wrap Up | AHA 2023
Eagle's Eye View: Your Weekly CV Update From ACC.org
00:00
Introduction
This chapter introduces the phase two trial called Azalea Timmy71, which evaluates the safety and efficacy of a novel agent called Abecidimap. The trial shows overwhelming benefits in terms of bleeding reduction and the speaker expresses optimism about its potential for further study.
Transcript
Play full episode
